Hydrocision
North Billerica, US · Delaware corporation · 2 known investors
HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner. The company serves surgeons and hospitals across multiple medical specialties seeking improved surgical outcomes.
Founders & leadership
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$5.5M disclosed across 2 rounds · 2017–2024
▶$2.5MraisedApr 2025 · 12 investors · BiotechnologyRule 506(b)
- PAUL KOWALSKIExecutive Officer
- DOUG WALLDirector
- TERRY WALLDirector
- LONG ZHANDirector
- BRYAN GRULKEDirector
- HOWARD W. DONNELLYDirector
- RICHARD A. LYTLE, IIIExecutive Officer, Director
- THOMAS D. ABERTExecutive Officer
- MARC E. GOLDBERGDirector
- Offering amount
- $3.9M
- Amount sold
- $2.5M
- Proceeds to insiders
- $100.1K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMar 2017 · 10 investors · BiotechnologyRule 506(b)
- DOUG WALLDirector
- TERRY WALLDirector
- YU XIAOTONGDirector
- PATRICIA VANBLARCOMExecutive Officer
- PAUL KOWALSKIExecutive Officer
- HOWARD DONNELLYDirector
- MARC GOLDBERGDirector
- Offering amount
- $4M
- Amount sold
- $3M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with Hydrocision for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Hydrocision do?
- HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner. The company serves surgeons and hospitals across multiple medical specialties seeking improved surgical outcomes.
- Who are Hydrocision's investors?
- Hydrocision's investors include Newbury Ventures, Oxford Bioscience Partners.
- How much funding has Hydrocision raised?
- Hydrocision has disclosed $5.5M raised across 2 rounds.
- Where is Hydrocision headquartered?
- Hydrocision is headquartered in North Billerica, US.


